EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer (Q79294407)
scientific article published on 23 October 2006
Language:
(P31) (Q13442814)
(P50) (Q37838131)
(Q41109465)
(P304) 99-103
(P433) 1
(P478) 18
(P577) Monday, October 23, 2006
(P921) (Q47912)
(P1433) (Q326122)
(P1476) "EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer" (language: en)
(P2093) L Boerrigter
H Ruijter
I Tielen
D de Jong
P Baas
S Burgers
P Nederlof
other details
description scientific article published on 23 October 2006

External Links